Neogenomics NEO Cash Flow Statement (2010-2026)

NASDAQ NEO
$17.60 +0.76 (+4.51%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Neogenomics Quarterly Cash Flow Statement

Periods 66 quarters
Latest Sep 2026

Neogenomics reported cash from operations of -$8.88M and free cash flow of -$20.66M for the quarter ended Sep 2026, down 200.0% year over year. This cash flow statement covers 66 quarters of results from Jun 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-41.76M-49.41M-35.30M-36.85M-22.69M-30.80M-24.33M-18.52M-14.33M-27.06M-18.64M-17.70M-15.32M-25.92M-45.09M-27.13M-9.88M-17.11M2.24M-7.55M
Depreciation and DepletionDep. & Depletion
8.39M8.40M8.53M8.97M9.48M9.05M9.48M9.35M9.58M9.91M9.75M9.62M9.83M9.37M9.14M8.80M8.76M8.78M8.58M8.56M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
8.48M8.49M8.49M8.49M8.59M8.78M8.78M8.78M8.78M8.36M8.36M8.36M8.36M8.36M8.12M7.63M7.63M7.63M7.63M7.63M
Amortization of Deferred ChargesAmort. Deferred Charges
0.66M0.66M0.66M0.67M0.67M0.67M0.67M0.67M0.68M0.68M0.68M0.68M0.68M0.69M0.48M0.37M0.37M0.46M
Depreciation & Amortization (CF)Dep. & Amort.
8.39M8.40M8.53M8.97M9.48M9.05M9.48M9.35M9.58M9.91M9.75M9.62M9.83M9.37M9.14M8.80M8.76M8.78M8.58M8.56M
Share-based CompensationStock Comp.
10.06M12.10M3.63M4.28M4.66M4.76M5.71M6.99M7.77M8.84M8.33M10.75M12.21M10.31M8.04M9.64M8.22M8.84M
Deferred Taxes
-3.77M-5.73M-3.29M-3.32M-3.04M-2.90M-3.44M-1.81M-0.80M-0.48M-0.24M-1.56M-0.54M-0.99M0.87M-2.69M-0.77M-0.63M-0.73M
Gains from Sales and DivestituresGains Divest
-0.44M2.05M-5.11M0.21M-0.33M0.04M0.11M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.72M0.92M0.74M0.04M0.15M0.17M20.04M7.09M0.67M
Other non-cash itemsOther Non-Cash
2.55M2.65M2.34M2.39M2.40M2.33M2.32M2.21M2.38M2.40M2.39M2.23M1.90M1.58M1.71M1.72M-11.18M
Change in Working Capital
Change in ReceivablesChange Receivables
7.17M-1.33M0.48M0.72M7.72M-0.87M6.58M7.22M-1.41M9.05M6.30M4.85M-0.89M0.67M-1.07M2.37M4.21M8.18M7.98M38.01M
Change in InventoryChange Inventory
1.56M0.45M-1.98M1.94M0.70M0.20M0.69M-0.64M0.20M-3.84M3.00M1.24M2.29M3.02M4.12M-5.63M0.03M1.27M-2.70M-1.64M
Change in Accrued ExpensesChange Accrued Exp.
-3.70M-5.99M4.34M1.33M2.15M-7.25M12.80M1.91M5.57M-18.55M13.57M3.99M10.28M-22.96M8.62M2.77M-4.10M-7.00M15.69M4.21M
Change in Other Operating AssetsOther Assets Change
-9.89M2.04M0.16M1.40M-2.45M1.19M1.43M2.55M-1.99M1.98M-2.29M1.52M5.63M3.11M-1.97M0.51M-3.21M1.40M1.46M-0.62M
Change in Other Operating LiabilitiesOther Liabilities Change
-2.83M-2.10M-2.15M-1.47M-1.72M-1.57M-2.58M-1.75M-1.43M-1.88M-0.98M-1.71M-1.09M0.90M-0.80M-1.23M-1.30M-1.30M-0.64M
Other Working Capital ChangesOther WC Changes
9.89M-4.88M-2.26M-3.56M0.97M-2.91M-3.00M-5.13M0.23M-3.41M0.42M-2.50M-7.34M-4.20M2.87M-1.31M1.97M-2.69M-2.76M-0.02M
Other Operating Activities (as filed)
0.72M1.13M0.48M-0.17M0.29M-0.03M0.04M0.12M0.06M-0.06M0.22M0.05M-0.03M0.77M-1.11M0.34M-0.33M0.40M-0.42M-0.10M
Cash from OperationsCash from Ops.
-19.78M-29.04M-17.00M-16.27M-3.69M-12.69M-1.55M-5.50M17.78M-25.92M13.89M9.25M9.80M-25.33M20.33M8.88M1.34M-8.14M19.96M-8.89M
Investing Activities
Capital ExpendituresCapex
11.99M8.22M10.29M7.84M4.53M9.93M7.49M4.27M7.06M5.59M13.08M10.80M11.60M4.50M6.32M8.31M7.87M5.00M8.22M11.77M
Change in Property, Plant and EquipmentChange in PP&E
-11.99M-8.22M-10.29M-7.84M-4.53M-9.93M-7.49M-4.27M-7.06M-5.59M-13.08M-10.80M-11.60M-4.50M-6.32M-8.31M-7.87M-5.00M-8.22M-11.77M
Change in IntangiblesChange Intangibless
Acquisitions
0.46M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.46M
Purchase of InvestmentsInvestments Purchased
15.83M16.17M40.17M17.64M23.63M6.76M
Sale and Maturity of InvestmentsInvestments Sold
36.44M32.09M21.29M54.21M40.43M22.44M25.10M48.50M20.11M20.39M7.28M6.13M8.06M3.00M9.00M
Other Investing Activities (as filed)Other investing (as filed)
-0.50M-0.08M
Cash from Investing ActivitiesCash from Investing
-9.58M12.05M-6.27M-4.20M-1.06M23.74M14.95M20.82M17.20M14.53M7.31M-3.52M-5.47M3.56M-9.31M-0.28M-6.31M-5.00M-8.32M-11.85M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.87M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.87M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
0.87M
Change in Capital Stock
Common Stock IssuedStock Issued
2.97M6.40M1.24M3.09M1.85M1.41M0.09M1.85M1.27M0.82M1.97M1.18M0.69M0.95M1.39M0.84M-2.21M-0.34M3.36M14.02M
Net Shares Issued and RepurchasedNet Shares Issued
2.97M6.40M1.24M3.09M1.85M1.41M0.09M1.85M1.27M0.82M1.97M1.18M0.69M0.95M1.39M0.84M-2.21M-0.34M3.36M14.02M
Net Equity Issued and RepurchasedNet Equity Issued
2.97M6.40M1.24M3.09M1.85M1.41M0.09M1.85M1.27M0.82M1.97M1.18M0.69M0.95M1.39M0.84M-2.21M-0.34M3.36M14.02M
Other financing activities (as filed)
-0.08M-0.40M
Cash from Financing ActivitiesCash from Financing
2.46M6.06M1.01M2.96M1.80M1.38M0.06M1.84M1.27M0.82M1.97M1.18M0.69M0.95M-202.43M0.77M0.43M-0.34M-12.24M14.48M
Additional items
Exchange Rate EffectFX Effect
0.02M
Change in Cash
-26.90M-10.93M-22.26M-17.51M-2.95M12.43M13.47M17.17M36.25M-10.57M23.17M6.91M5.02M-20.82M-191.47M9.39M-4.50M-13.48M-0.60M-6.26M
Ending Cash Balance
316.83M305.90M283.64M266.13M263.18M275.61M289.07M306.24M342.49M331.91M355.09M361.99M367.01M346.19M154.72M164.12M159.62M146.14M145.54M139.28M
Free Cash FlowFCF
-31.76M-37.26M-27.29M-24.12M-8.22M-22.62M-9.04M-9.77M10.73M-31.50M0.81M-1.55M-1.80M-29.83M14.01M0.57M-6.53M-13.14M11.74M-20.66M
Net Cash FlowNCF
-26.90M-10.93M-22.26M-17.51M-2.95M12.43M13.47M17.17M36.25M-10.57M23.17M6.91M5.02M-20.82M-191.42M9.37M-4.53M-13.48M-0.60M-6.26M
Interest Paid
1.27M0.44M1.70M0.00M1.26M0.43M1.26M0.43M1.26M0.43M1.26M0.45M1.69M0.00M1.26M0.43M0.00M0.43M0.30M0.10M
Income Taxes PaidTaxes Paid
0.04M0.13M0.03M0.03M0.18M0.09M0.09M0.14M-0.11M0.46M0.06M0.71M

Neogenomics Cash Flow Statement API

Pull Neogenomics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NEO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY